US Patent 7829537 Receptor associated protein (RAP) conjugates
Patent 7829537 was granted and assigned to Raptor Pharmaceuticals on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+160 characters)
Article
Patent abstract
The present invention is directed to a methods and compositions for receptor mediated drug delivery, particularly across the blood-brain barrier.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Christopher M. Starr0
Todd C. Zankel0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07829537 Receptor associated protein (RAP) conjugates US Patent 7829537 Receptor associated protein (RAP) conjugates
Infobox
Patent Number
078295370
Patent Number
78295370
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078295370
Date of Patent
November 9, 2010
0Patent Application Number
125089560
Date Filed
July 24, 2009
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07829537 Receptor associated protein (RAP) conjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07829537
Date of patent
November 9, 2010
Patent application number
12508956
Date Filed
July 24, 2009
Patent primary examiner
Find more entities like US Patent 7829537 Receptor associated protein (RAP) conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.